Poster Abstract Session:
245. HIV and HCV
Saturday, October 7, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Tracks: Adult ID, HIV-STD-TB, Investigative ID, Trainee

Longterm Evaluation of Hemoglobin A1c Following Hepatitis C Therapy in Patients with and without HIV Co-infection
Chloe Chaudhury, BS; Julia Sheehan, TBD; Cheryl Chairez, RN, BSN; Elizabeth Akoth, RN; Chloe Gross, RN, BSN, ACRN; Sarah Kattakuzhy, MD; Elana Rosenthal, MD; Shyam Kottilil, MD, PhD; Henry Masur, MD; Colleen Hadigan, MD, MPH
  • IDWeek HbA1c poster_final.pdf (332.2 kB)
  • Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 weeks in Patients Coinfected with HCV and HIV-1
    Peter Ruane, MD; Peter Buggisch, MD; ANA Moreno, MD, PhD; Vasily Isakov, MD; Lisa Backus, MD, PhD; Dani Ain, BS; Juan Gonzalez-Garcia, MD; Sarjita Naik, PharmD, MPH; Swarup Mehta, PharmD, MBA; Jina Lee, PharmD; Joe Llewellyn, PharmD; Michael Mertens, PhD; Macky Natha, MD, FRCP; Anu Osinusi, MD, MPH; Jihad Slim, MD; Konstantin Zhdanov, MD; Juan Berenguer, MD PhD; Stefan Zeuzem, MD
  • Ruane_P2225.pdf (407.5 kB)
  • Hepatitis C Virus Treatment Response to Ledipasvir/Sofosbuvir among patients co-infected with HIV and HCV: Real World Data in a Black Population
    Jaspreet Banga, MD, MPH; Sobia Nizami, MD; Jihad Slim, MD; Sandhya Nagarakanti, MD; Mario Portilla, RN; Shobha Swaminathan, MD
    Difference in SVR12 outcomes in the HIV/HCV co-infected population in New Orleans, Louisiana
    Tulsi Shah, MBBS; Yussef Bennani, MD, FIDSA; George Therapondos, MD; Christopher Parsons, MD, FIDSA; Randi Kendrick, MPH; Julia Garcia-Diaz, MD, FIDSA
    Sustained Virologic Response with Direct Acting Antivirals in HIV Coinfected Hepatitis C Patients and Its Effect on Liver Fibrosis
    Dora Lebron, MD; Alexandra Stang, MD; Alicia Lagasca, MD; Paul P. Cook, MD; Dawd Siraj, MD
  • ID WEEK 2017 Poster.pdf (1.1 MB)
  • Eliminating HCV co-infection in HIV: A Positive Health Clinic (PHC) Venture
    Arpan Shah, M.D; Cindy Magrini, PharmD; Lori Mezeivtch, PharmD; Chiu-Bin Hsiao, MD, FIDSA, AAHIVS
    Barriers to Hepatitis C Treatment in HIV co-infected Patients in the Era of new Direct-Acting Antiviral Therapy
    Caytlin Deering, DO; Dagan Coppock, MD; Suzanne Boyle, MD; Zsofia Szep, MD; Taneesa Franks, Research assistant; Tiffany Scott, Research Assistant; Anna Kesaris, Research Assistant; Edgar Chou, MD; Dong Heun Lee, MD
  • 2017_ID_Week_HIV_HCVBarrier.pdf (218.7 kB)
  • Hepatitis C and HIV Primary Care Screening Intervention Increases Identification and Linkage to Care within a Large Healthcare system
    Michael Leonard, MD; Sveta Mohanan, MD; Thomas Ludden, PhD; Lindsay Shade, PA-C, MHS; Jeremy Thomas, MSW; Hazel Tapp, PhD
    Viral Hepatitis among HIV+ Patients in Northern Vietnam
    Charan Mohan, BS; Tran Viet Ha, MD, MSc; Irving Hoffman, PA, MPH; Joseph Eron, MD; Vivian Go, PhD
  • poster_summer16.pdf (308.6 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.